Brief: Gensight Biologics Draws Down Second Tranche Of Bonds From Kreos Capital

Gensight Biologics SA

04/08/2020 06:46

Aug 4 (Reuters) - Gensight Biologics SA  SIGHT.PA :
    * GENSIGHT BIOLOGICS DRAWS DOWN THE €4 MILLION SECOND
TRANCHE OF
BONDS FROM KREOS CAPITAL
    * AGREEMENT WITH KREOS CAPITAL ALSO PROVIDES FOR A POSSIBLE
THIRD
TRANCHE OF EUR 2 MILLION THAT COULD BE MADE AVAILABLE AT A LATER
DATE
    * COMPANY HAS SUFFICIENT NET WORKING CAPITAL TO MEET ITS
OBLIGATIONS UNTIL MID-2021
    * UR 10 MILLION STRAIGHT BOND ISSUANCE DIVIDED INTO TWO
TRANCHES
OF EUR 6 MILLION AND, SUBJECT TO A QUALIFYING FINANCING, EUR 4
MILLION

Source text for Eikon:  ID:nBws8fCna 
Further company coverage:  SIGHT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))